A 68-year-old with a second CDI episode and multiple risk factors for recurrence asks about adjunct therapies. What option can be added to reduce recu...

Question

A 68-year-old with a second CDI episode and multiple risk factors for recurrence asks about adjunct therapies. What option can be added to reduce recurrence risk?

Accepted Answer

Add bezlotoxumab to standard therapy in high-risk recurrence

Answer

Probiotics

Answer

Loperamide

Answer

Cholestyramine

Answer

No adjuncts are available

us-abim MCQ (SBA): Recurrent C. difficile (Prevention)

A 68-year-old with a second CDI episode and multiple risk factors for recurrence asks about adjunct therapies. What option can be added to reduce recurrence risk?